Biological markers in CSF and blood for axonal degeneration in multiple sclerosis
- 1 January 2005
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 4 (1) , 32-41
- https://doi.org/10.1016/s1474-4422(04)00964-0
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Proteomic analysis of cerebrospinal fluid from multiple sclerosis patientsProteomics, 2004
- Biomarkers for Alzheimer’s disease. Which way to go?Neurobiology of Aging, 2003
- Imaging neuronal and axonal degeneration in multiple sclerosisNeurological Sciences, 2003
- 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosisZeitschrift für Neurologie, 2002
- Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosisMultiple Sclerosis Journal, 2000
- Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosisMultiple Sclerosis Journal, 1999
- Quantification of Axonal Damage in Traumatic Brain InjuryJournal of Neurochemistry, 1999
- Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosisMultiple Sclerosis Journal, 1998
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system.Journal of Neurology, Neurosurgery & Psychiatry, 1983